Clinical Variant Interpreter

Integrate population, ClinVar, ClinGen, OMIM, and literature data to classify genetic variants with ACMG criteria.

1.6k|244|Updated Mar 3, 2025
One-click install
npx skills add https://github.com/mims-harvard/ToolUniverse --skill clinical-variant-interpreter
Or copy as Structured Prompt for Agent
Please help me install this Agent Skill.
Skill: Clinical Variant Interpreter
Source: https://github.com/mims-harvard/ToolUniverse/tree/main/skills/tooluniverse-variant-interpretation
Command: npx skills add https://github.com/mims-harvard/ToolUniverse --skill clinical-variant-interpreter

SYSTEM DOCUMENTATION & REQUIREMENTS

What problem does it solve?

This Skill provides an end-to-end workflow for variant interpretation that integrates population data, ClinVar, ClinGen, OMIM, structural context (via AlphaFold2 and PDB), and literature to produce ACMG-classified results with clear clinical recommendations.

Core Features & Use Cases

  • ACMG-guided classification with explicit evidence codes (PVS, PS, PM, PP, BA/BS/BP).
  • Integrated data landscape: gnomAD, ClinVar, ClinGen, OMIM, PubMed, and primary literature for robust evidence synthesis.
  • Structural analysis for missense variants using AlphaFold2/PDB context to support PM1/PP3 considerations.
  • Output includes actionable clinical recommendations and family testing guidance, with limitations and uncertainties.
  • Use Case: Interpret a BRCA1 variant to determine pathogenicity and outline risk management steps.

Quick Start

Interpret NM_007294.4:c.5266dupC in BRCA1 to produce an ACMG classification with explicit evidence and clinical recommendations.

Frequently Asked Questions about Clinical Variant Interpreter

High-intent search queries and answers about installing and using this skill.

FAQPage Schema
How do I classify genetic variants using ACMG guidelines and structural analysis?

You can classify genetic variants by integrating population data from gnomAD, ClinVar, ClinGen, OMIM, and literature, then applying structural analysis using AlphaFold2 and PDB context to produce ACMG-classified results with explicit evidence codes.

What is the best way to interpret a BRCA1 variant for clinical pathogenicity?

To interpret a BRCA1 variant, integrate population frequency data, ClinVar records, and structural context to generate an ACMG classification, actionable clinical recommendations, and family-testing guidance with clearly stated limitations.

Does AlphaFold2 structural analysis support ACMG variant interpretation for missense mutations?

AlphaFold2 structural analysis supports ACMG variant interpretation by providing PDB context to assess missense variants, specifically supporting PM1 and PP3 evidence considerations for clinical pathogenicity classification.

How do I get explicit ACMG evidence codes for clinical variant interpretation?

Clinical variant interpretation generates explicit ACMG evidence codes including PVS, PS, PM, PP, BA, BS, and BP by synthesizing data from gnomAD, ClinVar, ClinGen, OMIM, PubMed, and primary literature.

Can I use gnomAD and ClinVar data together for clinical variant interpretation?

Yes, clinical variant interpretation integrates gnomAD population data with ClinVar, ClinGen, OMIM, and literature to synthesize robust evidence for ACMG-guided classification and actionable clinical recommendations.

What limitations should I expect when using AlphaFold2 for clinical variant interpretation?

Clinical variant interpretation using AlphaFold2 provides structural context for missense variants but returns explicit limitations and uncertainties alongside ACMG classifications, clinical recommendations, and family-testing guidance to ensure transparent results.